CYYNF
Price
$0.08
Change
-$0.07 (-46.67%)
Updated
Jun 12 closing price
Capitalization
27.19M
HLOSF
Price
$3.44
Change
+$0.73 (+27.04%)
Updated
Jul 14 closing price
Capitalization
478.41M
Interact to see
Advertisement

CYYNF vs HLOSF

Header iconCYYNF vs HLOSF Comparison
Open Charts CYYNF vs HLOSFBanner chart's image
Cynata Therapeutics
Price$0.08
Change-$0.07 (-46.67%)
Volume$20K
Capitalization27.19M
HEALIOS K K
Price$3.44
Change+$0.73 (+27.04%)
Volume$100
Capitalization478.41M
CYYNF vs HLOSF Comparison Chart in %
Loading...
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYYNF vs. HLOSF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYYNF is a Hold and HLOSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CYYNF: $0.08 vs. HLOSF: $3.43)
Brand notoriety: CYYNF and HLOSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYYNF: 172% vs. HLOSF: 69%
Market capitalization -- CYYNF: $27.19M vs. HLOSF: $478.41M
CYYNF [@Biotechnology] is valued at $27.19M. HLOSF’s [@Biotechnology] market capitalization is $478.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYYNF’s FA Score shows that 1 FA rating(s) are green whileHLOSF’s FA Score has 0 green FA rating(s).

  • CYYNF’s FA Score: 1 green, 4 red.
  • HLOSF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYYNF and HLOSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYYNF’s TA Score shows that 3 TA indicator(s) are bullish while HLOSF’s TA Score has 4 bullish TA indicator(s).

  • CYYNF’s TA Score: 3 bullish, 3 bearish.
  • HLOSF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, HLOSF is a better buy in the short-term than CYYNF.

Price Growth

CYYNF (@Biotechnology) experienced а 0.00% price change this week, while HLOSF (@Biotechnology) price change was +27.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($478M) has a higher market cap than CYYNF($27.2M). HLOSF YTD gains are higher at: 154.444 vs. CYYNF (-57.895).
CYYNFHLOSFCYYNF / HLOSF
Capitalization27.2M478M6%
EBITDA-10.8MN/A-
Gain YTD-57.895154.444-37%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CYYNF: Fundamental Ratings
CYYNF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYYNFHLOSF
RSI
ODDS (%)
Bullish Trend 6 days ago
38%
Bearish Trend 4 days ago
40%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
56%
Momentum
ODDS (%)
Bullish Trend 4 days ago
26%
Bullish Trend 4 days ago
38%
MACD
ODDS (%)
Bullish Trend 4 days ago
31%
Bullish Trend 4 days ago
9%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
18%
Bullish Trend 4 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
15%
Bullish Trend 4 days ago
10%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
33%
Aroon
ODDS (%)
Bearish Trend 4 days ago
27%
Bullish Trend 4 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CESGX11.55N/A
N/A
Coho Relative Value ESG
NWAPX35.77N/A
N/A
Nationwide BNY Mellon Dyn US Eq Inc Egl
NOMIX21.20-0.01
-0.05%
Northern Mid Cap Index
TGADX30.30-0.04
-0.13%
Templeton Growth Adv
WEMAX10.06-0.02
-0.20%
Allspring Emerging Growth A

CYYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with HLOSF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then HLOSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
HLOSF - CYYNF
39%
Loosely correlated
N/A
DMAC - CYYNF
30%
Poorly correlated
+6.36%
PALI - CYYNF
21%
Poorly correlated
+0.56%
CVALF - CYYNF
6%
Poorly correlated
+0.53%
ELVAF - CYYNF
0%
Poorly correlated
N/A
More

HLOSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLOSF has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HLOSF jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
ORKA - HLOSF
62%
Loosely correlated
-5.34%
PCVX - HLOSF
39%
Loosely correlated
-0.98%
CYYNF - HLOSF
39%
Loosely correlated
N/A
FHTX - HLOSF
23%
Poorly correlated
+0.49%
DMAC - HLOSF
22%
Poorly correlated
+6.36%
More